List of works by Paul A Beavis

A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells

scientific article published on 12 January 2017

A2A blockade enhances anti-metastatic immune responses

scientific article published on 22 October 2013

Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses

scientific article

Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity

scientific article published on 18 May 2020

Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer

scientific article published on 19 September 2017

Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells

scientific article published on 19 July 2013

Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors

scientific article published on 20 August 2013

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

scientific article published on 17 June 2013

CD73-deficient mice are resistant to carcinogenesis

scientific article

CD73: A potential biomarker for anti-PD-1 therapy

scientific article

CD73: a potent suppressor of antitumor immune responses

scientific article published on 07 April 2012

Cross-talk between tumors can affect responses to therapy

scientific article published on 17 June 2015

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.

scientific article published on 13 December 2016

Enhancing the efficacy of adoptive cellular therapy by targeting tumor-induced immunosuppression

scientific article published on June 2015

MAIT cells regulate NK cell-mediated tumor immunity

scientific article published on 06 August 2021

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

scientific article published on 21 October 2019

RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors

scientific article published on 29 October 2015

Relevance of tumor-infiltrating lymphocytes in breast cancer

scientific article (publication date: 2015)

Reprogramming the tumor microenvironment to enhance adoptive cellular therapy

scientific article

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

scientific article

Targeting the epigenetic regulation of antitumour immunity

scientific article published on 14 September 2020

Paulina is supported by:

About Paulina

Help